Sign up
Log in
Why Is NuCana (NCNA) Stock Down Today?
Share
Listen to the news

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

NuCana (NASDAQ:NCNA) stock is sliding lower on Tuesday as the clinical-stage biopharmaceutical company prepares for a presentation this week.

NuCana is set to attend the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 in Boston, Mass. This conference starts on Wednesday and will last through Sunday.

NuCana will be holding multiple presentations at the event. That includes updates on its clinical trials, as well as information from other studies the company is conducting. Two of these presentations will take place on Friday and the other two will take place on Saturday.

Breaking down those topics further, NuCana intends to cover NUC-3373 in combination with irinotecan, its Phase II study of NUC-3373, its Phase Ib/II study of NUC-3373 in combination with pembrolizumab and NUC-7738 in combination with pembrolizumab.

How This Affects NCNA Stock Today

Typically, investors might expect shares of a company’s stock to rally ahead of a presentation but we aren’t seeing that with NCNA stock on Tuesday. Instead, NuCana stock is taking a 3.1% beating as of this writing. Investors will also note that these shares are down 23% year-to-date as of Monday’s close. However, the presentations could become a positive catalyst for those shares.

NCNA stock isn’t seeing much in the way of trading today. Only about 1,000 shares have changed hands as of Tuesday morning. For the record, its daily average trading volume is closer to 44,000 shares.

Investors keeping tabs on all of the latest stock market news today will want to keep reading!

We’re offering insight into all of the hottest stock market stories for Tuesday! That includes everything happening with Borqs Technologies (NASDAQ:BRQS) stock, Mobilicom (NASDAQ:MOB) stock and SuperCom (NASDAQ:SPCB) stock today. You can learn all about these topics below!

More Stock Market News for Tuesday

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that  InvestorPlace.com’s writers disclose this fact and warn readers of the risks. 

Read More:Penny Stocks — How to Profit Without Getting Scammed

More From InvestorPlace

The post Why Is NuCana (NCNA) Stock Down Today? appeared first on InvestorPlace.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.